Browsing “Patient Support & AdherencePatient Support & Adherence | EVERSANA”

Advancing Beyond the Traditional Patient Adherence Model

Delivering value in the era of empowered patients renders the one-size-fit-all patient services program obsolete. Not every treatment journey is consistently linear within a disease state because patients take different paths to medication adherence. For example, one patient may be compliant when prompted by a smartphone notification while another relies on a caregiver for their […]

Accelerating Rare Liver Disease Study Enrollment

An emerging clinical stage biotech contracted with EVERSANA to conduct Phase II trial enrollment support for an ultra-rare liver disease through our Seeker Health platform. Because of the ultra-rare patient population and nature of the therapy, the client expected significant recruitment challenges. Read more, download the full case study: Learn more about Seeker Health® by […]

Where Health Systems are in the Shift to Value: Four Categories

One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health systems in successfully transitioning to value-based care and delivering improved clinical and financial outcomes for their patient populations depends on very different […]

PharmaVOICE Connected Health Showcase

IF I COULD ONLY ASK TWO QUESTIONS, THE FIRST WOULD BE: What is your data integration and analytics platform strategy? As the industry continues its shift to a patient-centric, value-based model of care, it is critical that the next generation of patient services programs integrate data and analytics into their care models to track the […]

New Product Commercialization – Webinar

Q. How do you successfully commercialize a new product in the new era of “patient-as-consumer” and “outcomes-based healthcare”? A. You design and deliver an engaging, high-touch patient experience. In this 30 minute webinar, Tom Doyle explains how manufacturers historically relied on a one-size-fits-all HUB model that utilized benchmark data from products in similar therapeutic classes […]

Strategies to Ensure Market Success of a Rare Disease Product Launch

Small patient populations, complex administration, high costs of therapies, and government policy interventions are just a few obstacles in rare disease. EVERSANA’s Managing Director, Bill O’Bryon, and Senior Director, Diann Johnson, outline key insights to consider in your launch strategy: Market dynamics impacting rare disease therapies The entire rare community: patients, caregivers, providers & advocates […]

Gross-to-Net Improvement Through Holistic Revenue Enhancement

Consistent price increases have long been a staple of commercial strategy for pharmaceutical manufacturers. From this uplift in topline revenue, more sizable discounts can be provided to industry middlemen, like pharmacy benefit managers (PBMs), in order to secure more favorable formulary positioning. Rather than continue forward with traditional market access strategies, manufacturers should consider revenue […]

Adopting a Patient-Centric Approach to Ensure Safe and Effective Use

Healthcare leaders often talk about ensuring that the right patient receives the right medication at the right time. On its face, this concept seems straightforward. We know that different patients respond differently to different therapies, such that we cannot consistently replicate randomized clinical trial experience in the real world. Thus, healthcare providers (HCPs) must make […]

Patients at the Center of Safe and Effective Therapy

First, do no harm. This phrase is synonymous with the Hippocratic oath, the oldest reference to ethics in Western medicine, and it highlights what is generally considered most important in a physician’s medical practice. Help if you can, but not at the risk of further injury to the patient. The spirit of this oath carries […]

Are You Ready For Patient Services 2.0?

Today’s patients are far more engaged than the previous era of “doctor knows best.” And, like all modern consumers, they expect outcomes to be personalized, delivered on their terms, powered by technology, and of high value. As a result, the next generation of patient services can no longer depend on the “one-size-fits-all” model. Manufacturers can […]